Absci Ownership | Who Owns Absci?
Absci Ownership Summary
Absci is owned by 10.31% institutional investors, 13.08% insiders, and 76.60% retail investors. Fmr is the largest institutional shareholder, holding 17.31% of ABSI shares. ARK Genomic Revolution ETF is the top mutual fund, with 7.90% of its assets in Absci shares.
ABSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Absci | 10.31% | 13.08% | 76.60% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 22.08M | 17.31% | $67.13M |
| Ark investment management | 12.55M | 8.73% | $43.80M |
| Blackrock funding, inc. /de | 11.33M | 7.88% | $39.55M |
| Redmile group | 8.25M | 6.47% | $25.09M |
| Vanguard group | 7.91M | 5.50% | $27.61M |
| Blackrock | 5.34M | 5.38% | $16.46M |
| Ameriprise financial | 3.19M | 2.50% | $9.70B |
| Geode capital management | 3.24M | 2.25% | $11.31M |
| Ubs group | 2.70M | 1.88% | $9.42M |
| State street | 2.06M | 1.62% | $6.28M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 8.25M | 2.44% | $25.09M |
| Heights capital management | 2.00M | 1.67% | $6.08M |
| Great point partners | 796.44K | 1.00% | $2.42M |
| Ark investment management | 12.55M | 0.29% | $43.80M |
| Casdin capital | 973.26K | 0.25% | $2.96M |
| Pier 88 investment partners | 205.80K | 0.16% | $718.24K |
| Iq eq fund management (ireland) | 470.39K | 0.11% | $1.64M |
| Nikko asset management americas | 1.42M | 0.06% | $4.96M |
| Institute for wealth management, llc. | 145.79K | 0.05% | $508.81K |
| Dkm wealth management | 20.00K | 0.05% | $69.80K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 5.34M | 0.00% | 4.45M |
| Fmr | 22.08M | 0.00% | 2.95M |
| Heights capital management | 2.00M | 1.67% | 2.00M |
| Great point partners | 796.44K | 1.00% | 796.44K |
| Blackrock funding, inc. /de | 11.33M | 0.00% | 750.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fred alger management | 1.23M | 0.01% | -2.70M |
| Woodline partners lp | 1.77M | 0.03% | -1.20M |
| Laurion capital management lp | - | - | -1.19M |
| Millennium management | 25.23K | - | -1.15M |
| Affinity asset advisors | - | - | -1.02M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Heights capital management | 2.00M | 1.67% | 2.00M | $6.08M |
| Great point partners | 796.44K | 1.00% | 796.44K | $2.42M |
| Exoduspoint capital management, lp | 79.76K | 0.00% | 79.76K | $242.48K |
| Profund advisors | 76.49K | 0.01% | 76.49K | $266.95K |
| Atom investors lp | 48.86K | 0.01% | 48.86K | $148.53K |
Sold Out
| Holder | Change |
|---|---|
| Pineridge advisors | -1.00 |
| Federated hermes | -3.00 |
| True wealth design | -9.00 |
| Capital performance advisors llp | -11.00 |
| Riggs asset managment | -78.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | -73.15% | 14,828,343 | -84.67% | 10 | 0.18% | 16 | -80.00% | 7 | -79.41% |
| Sep 30, 2025 | 52 | -61.48% | 14,647,739 | -83.64% | 11 | 0.23% | 24 | -67.12% | 8 | -76.47% |
| Jun 30, 2025 | 134 | -8.22% | 89,499,197 | 4.64% | 70 | 1.49% | 72 | -14.29% | 34 | - |
| Mar 31, 2025 | 146 | 7.35% | 85,529,834 | 15.75% | 68 | 1.62% | 85 | 8.97% | 33 | 6.45% |
| Dec 31, 2024 | 134 | 5.51% | 73,861,284 | 2.04% | 65 | 1.60% | 76 | 18.75% | 31 | -8.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 11.88M | 7.90% | - |
| ARK Genomic Revolution | 11.55M | 7.68% | 460.39K |
| Fidelity Growth Compy Commingled Pl S | 9.82M | 6.53% | 14.28K |
| Fidelity Growth Compy Commingled Pl O | 5.75M | 5.06% | - |
| Fidelity Growth Company Fund | 6.85M | 4.55% | -38.59K |
| Vanguard Total Stock Mkt Idx Inv | 4.25M | 2.83% | 65.30K |
| State Street® SPDR® S&P® Biotech ETF | 3.51M | 2.33% | -18.90K |
| iShares Russell 2000 ETF | 3.33M | 2.22% | 2.18M |
| Columbia Acorn Inst | 2.57M | 1.71% | - |
| Alger Small Cap Focus Composite | 2.47M | 1.65% | -290.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 02, 2026 | McClain Sean | Chief Executive Officer | Sell | $80.02K |
| Feb 02, 2026 | Jonasson Zachariah | CFO / CBO | Sell | $52.31K |
| Dec 05, 2025 | VAN HOUTEN FRANS | - | Buy | $148.80K |
| Sep 22, 2025 | Pangalos Menelas N | - | Buy | $254.79K |
| Sep 22, 2025 | Bedrick Todd | SVP, CAO | Buy | $27.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 2 |
| 2025 Q4 | 1 | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ABSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools